Drug intelligence / Profile preview

Relief

Development stage: Unknown
Lead developer: EO Care
Modality: Small Molecules
Administration: Oral

Overview

Relief is a clinician-designed, hemp-based consumer wellness product developed by EO Care for the management of symptoms, particularly those related to cancer and its treatment. As part of a specialized product line that includes Vitality, Boost, Clarity, and Rest, Relief utilizes hemp-derived cannabinoids to address patient-reported issues such as pain and physical discomfort. The product's efficacy is monitored using PROMIS (Patient-Reported Outcomes Measurement Information System) metrics, and it is integrated into personalized care plans overseen by medical professionals, including pharmacists and clinicians specializing in cannabis. It is marketed as a consumer wellness solution rather than a traditional pharmaceutical drug.

Brand names: Relief
Other names: EO Care Relief

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on Relief.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relief.

Explore the full profile